Biologic Drugs With Established Pharmaceutical Class: Interleukin-17A Antagonist
✉ Email this page to a colleague
Biologic Drugs With Established Pharmaceutical Class: Interleukin-17A Antagonist
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | COSENTYX | secukinumab | Injection | 125504 | 2015-01-21 | ⤷ Start Trial | ⤷ Start Trial |
| Novartis Pharmaceuticals Corporation | COSENTYX | secukinumab | Injection | 125504 | 2015-01-21 | 7,807,155 | ⤷ Start Trial |
| Novartis Pharmaceuticals Corporation | COSENTYX | secukinumab | Injection | 125504 | 2015-01-21 | 78,071,557,807,155 | ⤷ Start Trial |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |
